Skip to main content
. 2021 May 4;40(5):1200–1206. doi: 10.1002/nau.24682

Table 1.

Demographics of the unmatched and matched cohorts of people with and without COVID‐19

Unmatched cohorts Matched cohorts
COVID‐19 Cohort Non‐COVID‐19 cohort Standardized difference COVID‐19 Cohort Non‐COVID‐19 cohort Standardized difference a
n = 5620 n = 2,656,654 n = 5617 n = 11,225
Demographics
Age (median, IQR) 81 (73–88) 74 (70–81) 0.52 81 (73–88) 81 (72–88) 0b
Female, N (%) 2134 (38.0%) 1,417,611 (53.4%) 0.31 2134 (38.0%) 4268 (38.0%) 0b
Highest income quintile 1586 (28.2%) 543,536 (20.5%) 0.18 1585 (28.2%) 2827 (25.2%) 7%
Lowest income quintile 914 (16.3%) 536,212 (20.2%) 0.1 914 (16.3%) 1951 (17.4%) 3%
Residing in long term care, N (%) 2851 (50.7%) 60,142 (2.3%) 1.31 2848 (50.7%) 5687 (50.7%) 0b
Comorbidities in the previous 2 years, N (%)
COPD 459 (8.2%) 144,742 (5.4%) 0.11 459 (8.2%) 923 (8.2%) 0
Diabetes 1563 (27.8%) 523,953 (19.7%) 0.19 1562 (27.8%) 2420 (21.6%) 15%
Congestive heart failure 655 (11.7%) 129,219 (4.9%) 0.25 654 (11.6%) 982 (8.7%) 9%
Hypertension 2275 (40.5%) 759,355 (28.6%) 0.25 2274 (40.5%) 3170 (28.2%) 26%
Heart disease 311 (5.5%) 96,015 (3.6%) 0.09 310 (5.5%) 501 (4.5%) 5%
Stroke/TIA 584 (10.4%) 72,057 (2.7%) 0.31 584 (10.4%) 880 (7.8%) 9%
Obesity 138 (2.5%) 53,402 (2.0%) 0.03 138 (2.5%) 149 (1.3%) 8%
Chronic kidney disease 366 (6.5%) 108,554 (4.1%) 0.11 365 (6.5%) 537 (4.8%) 7%
Cancer 409 (7.3%) 187,737 (7.1%) 0.01 409 (7.3%) 709 (6.3%) 4%
Prior urologist visit 615 (10.9%) 260,107 (9.8%) 0.04 615 (10.9%) 1049 (9.3%) 5%

Abbreviations: IQR, interquartile range; COPD, chronic obstructive pulmonary disease; COVID‐19, coronavirus disease 2109; TIA, transient ischemic attack.

a

Standardized differences are better at demonstrating potentially clinically relevant differences (>10%) between large groups.

b

The variables age, sex, and residing in long‐term care were used to create the matched cohorts.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.